Yayınlar & Eserler

Yayın Ağı
Makaleler 28
Tümü (28)
SCI-E, SSCI, AHCI (15)
SCI-E, SSCI, AHCI, ESCI (16)
ESCI (1)
Scopus (21)
TRDizin (12)
Diğer Yayınlar (1)

1. Protective Effects of Luteolin Against Cisplatin-Induced Hepatic and Renal Toxicity: Biochemical and Cellular Evidence

Temiz Ö., KIZILYILDIRIM S., ÖZDEMİR SANCI T., TERZİ E., ÖZ BEDİR B. E., Akyuz M., et al.
Journal of Biochemical and Molecular Toxicology , cilt.40, sa.9, 2026 (SCI-Expanded, Scopus)

2. Design, Synthesis, and In Vitro Biological Assessment of Novel Benzimidazole and Hydrazone Derivatives Against Pancreatic Cancer and Melanoma Cells

ÖZ BEDİR B. E., ÖZDEMİR SANCI T., TERZİ E., ERCAN E., Daoud N. E., Çevik U. A.
Chemical Biology and Drug Design , cilt.107, sa.6, 2026 (SCI-Expanded, Scopus)

3. Comparative Cytotoxic and Anti-Migratory Effects of Cisplatin and Theobromine in Human Bladder Cancer Cells

ÖZ BEDİR B. E., ÖZDEMİR SANCI T., TERZİ E.
Archives of current medical research (ACMR) (Online) , cilt.7, 2026 (TRDizin)

4. Synthesis, characterization, and anticancer screening of novel thiadiazole derivatives

Özdemir Sancı T., Terzi E., Öz Bedir B. E., Halimi G., Acar Çevik U., Melfi F.
JOURNAL OF MOLECULAR STRUCTURE , cilt.145212, ss.1-9, 2026 (SCI-Expanded, Scopus)

5. Selective cytotoxicity of Arctium extracts in pancreatic, bladder, and colorectal cancer cell lines: A comparative dose-response study

ÖZDEMİR SANCI T., ÖZ BEDİR B. E., TERZİ E., KALAYCI B., AYDIN T., ÖZGÖKÇE F., et al.
INTERNATIONAL JOURNAL OF SECONDARY METABOLITE , 2026 (Scopus, TRDizin)

6. Thiazole- and 1,3,4-Thiadiazole-Based Hybrids: Synthesis and In Vitro Cytotoxicity Against Human Cancer Cell Lines

TERZİ E., ÖZDEMİR SANCI T., ÖZ BEDİR B. E., ERCAN E., Bağcı E. R., Çevik U. A., et al.
Chemical Biology and Drug Design , cilt.107, sa.2, 2026 (SCI-Expanded, Scopus)

7. Assessment of theobromine-induced cytotoxicity in bladder cancer cell lines: Determination of IC50 values step-by-step using RStudio

ERCAN E., TERZİ E., ÖZDEMİR SANCI T., ÖZ BEDİR B. E.
TURK HIJIYEN VE DENEYSEL BIYOLOJI DERGISI. TURKISH BULLETIN OF HYGIENE AND EXPERIMENTAL BIOLOGY , cilt.83, 2026 (Scopus, TRDizin)

8. Theobromine as a molecular switch: targeting Nrf2 pathway in invasive and non-invasive bladder cancer

ÖZ BEDİR B. E., ERCAN E., TERZİ E., ÖZDEMİR SANCI T.
Journal of Natural Medicines , cilt.80, sa.1, ss.64-75, 2026 (SCI-Expanded, Scopus)

9. Exploring Natural Coumarins: Breakthroughs in Anticancer Therapeutics

TERZİ E., ÖZ BEDİR B. E., Winum J.
Anti-Cancer Agents in Medicinal Chemistry , cilt.26, sa.8, ss.756-775, 2026 (SCI-Expanded, Scopus)

10. Targeting Ras Signaling via Carbonic Anhydrase IX Inhibition: Differential Impact of Acetazolamide on Clear Cell Renal Carcinoma and Melanoma Cells

Terzi E., Öz Bedir B. E., Çarhan A., Özensoy Güler Ö.
EXPERIMED , cilt.15, sa.3, ss.1-8, 2025 (ESCI, Scopus, TRDizin)

11. Targeting Carbonic Anhydrase IX Suppresses MAPK Activity and Viability in BRAF-Mutant Melanoma

Öz Bedir B. E., Özensoy Güler Ö.
Bratislava Medical Journal , cilt.126, sa.10, ss.2615-2627, 2025 (SCI-Expanded, Scopus)

12. Comparison of the effects of β-Arbutin on the NF-κB pathway in two-dimensional (2D) and three-dimensional (3D) colorectal cancer cell lines

TERZİ E., ÖZDEMİR SANCI T., ÖZ BEDİR B. E., GENECİ F., Jafarova S., Aydin T.
Chemico-Biological Interactions , cilt.416, 2025 (SCI-Expanded, Scopus)

13. Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel Benzothiazole-Based 1,3,4-Thiadiazole Derivatives as Potential Anticancer Agents.

Bedir B. E., Terzi E., Sanci T. O., Melfi F., Kaya-Sezginer E., Kaya B., et al.
Anti-cancer agents in medicinal chemistry , 2025 (SCI-Expanded, Scopus)

14. β-Arbutin and cisplatin: A combined approach to modulating apoptosis, cell viability, and migration in bladder cancer cells

TERZİ E., ÖZ BEDİR B. E., ERCAN E., ÖZDEMİR SANCI T., Jafarova S., Aydin T.
Toxicology in Vitro , cilt.104, 2025 (SCI-Expanded, Scopus) Creative Commons License

15. Design, Synthesis, and Biological Evaluation of New Benzimidazole-1,2,4-Triazole Derivatives as Potential Anticancer Agents

KAYA SEZGİNER E., ÖZ BEDİR B. E., TERZİ E., ÖZDEMİR SANCI T., Maryam Z., ACAR ÇEVİK U.
Chemical Biology and Drug Design , cilt.104, sa.6, 2024 (SCI-Expanded, Scopus)

16. In vitro anticancer effect of theobromine in A549 non-small cell lung cancer cells

ÖZ BEDİR B. E., ÖZDEMİR SANCI T., ERCAN E., KAYA SEZGİNER E., TERZİ E.
Int J Med Biochem , cilt.7, sa.3, ss.143-149, 2024 (Hakemli Dergi)

17. A Clinical Sulfonamide Derivative Inhibits B-Raf Protein in Colorectal Cancer and Melanoma Cells. Is It a New Target for Cancer?

TERZİ E., ÖZ BEDİR B. E.
Experimed , cilt.14, sa.1, ss.7-12, 2024 (Scopus)

18. The Effect of Thymoquinone on the Protein Levels of PLA2G7, UCP2, and NEDD4L Genes Associated with Lipid Droplets Formation in Prostate Cancer

HADJMIMOUNE A., ÇARHAN A., ÖZ BEDİR B. E., YILMAZ H., ERCİN M. E., ŞİMŞEK E.
Online Türk Sağlık Bilimleri Dergisi , cilt.9, sa.1, ss.97-102, 2024 (TRDizin)

19. Effect of Herniarin on Cell Viability, Cell Cycle, and Erk Protein Levels in Different Stages of Bladder Cancer Cells.

Sanci T., TERZİ E., ÖZ BEDİR B. E., Gumustas M., Aydin T., Cakir A.
Chemistry & biodiversity , cilt.21, sa.3, 2024 (SCI-Expanded, Scopus)

20. EZH2 gene and CA-IX prompt relation: An effective therapeutic target approach for melanoma progression

ÖZENSOY GÜLER Ö., ÖZ BEDİR B. E., TERZİ E.
International Journal of Medical Biochemistry , cilt.7, sa.1, ss.13-17, 2024 (Scopus, TRDizin)

21. Comparison of Apoptotic Effects of Rapamycin and Vemurafenib in Colorectal Cancer

NAKKAŞ H., ÖZDEMİR SANCI T., ÖZ BEDİR B. E., TERZİ E.
Uludağ Üniversitesi Tıp Fakültesi Dergisi , cilt.49, 2023 (TRDizin)

22. Differential in vitro Effects of Oncogenic Pathway Inhibitors on Carbonic Anhydrase- IX, Xanthine Oxidase and Catalase in Colorectal Cancer

ÖZ BEDİR B. E., TERZİ E., ÖZENSOY GÜLER Ö.
International Journal of Medical Biochemistry , cilt.6, ss.36-41, 2023 (Scopus, TRDizin) Sürdürülebilir Kalkınma

23. A new therapeutic target in the glutathione mechanism: Inhibition of tumor-associated CA-IX isoenzyme and oxidative stress

TERZİ E., ÖZ BEDİR B. E., ÖZENSOY GÜLER Ö.
Uludağ Üniversitesi Tıp Fakültesi Dergisi , cilt.48, ss.161-166, 2022 (TRDizin)

24. HIF-1 inhibitors: differential effects of Acriflavine and Echinomycin on tumor associated CA-IX enzyme and VEGF in melanoma Melanomda HIF-1 inhibitörleri olan Akriflavin ve Ekinomisin’in tümör ilişkili CA-IX enzimi ve VEGF proteini üzerine inhibisyon etkilerinin incelenmesi

Bedir B. E. Ö., TERZİ E., ŞİMŞEK E., Karakuş İ., UYSAL T. K., ERCAN E., et al.
Turkish Journal of Biochemistry , cilt.46, sa.6, ss.679-684, 2021 (SCI-Expanded, Scopus, TRDizin)

25. Gebelikte enzimler: sitozolik karbonik anhidraz, katalaz, paraoksonaz 1 ve ksantin oksidaz düzeyleri

Şimşek E., Yavuz A. F., Terzi E., Uysal T. K., Öz Bedir B. E., Haqverdiyev E., et al.
Online Türk Sağlık Bilimleri Dergisi , cilt.4, sa.1, ss.79-93, 2019 (TRDizin) Creative Commons License

26. Do CO 2 and oxidative stress induce cancer?: a brief study about the evaluation of PON 1, CAT, CA and XO enzyme levels on head and neck cancer patients

Mutlu M., Korkmaz M. H., Simsek E., Terzi E., Bedir B. E., Uysal T. K., et al.
Journal of Enzyme Inhibition and Medicinal Chemistry , cilt.34, sa.1, ss.459-464, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Enzymes During Pregnancy: Cytosolic Carbonic Anhydrase, Catalase, Paraoxonase 1 and Xanthine Oxidase Levels

ŞİMŞEK E., YAVUZ A. F., TERZİ E., ÖZ BEDİR B. E., UYSAL T. K., haqverdiyev e., et al.
Online Türk Sağlık Bilimleri Dergisi , 2019 (TRDizin)

28. Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives.

Awadallah F. M., El-Waei T. A., Hanna M. M., Abbas S. E., Ceruso M., Oz B. E., et al.
European journal of medicinal chemistry , cilt.96, ss.425-35, 2015 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 32

1. THEOBROMINE AS A NATURAL SCAFFOLD FOR ANTICANCER DRUG DESIGN: DOCKING AND ADMET-BASED INSIGHTS

TERZİ E., ÖZ BEDİR B. E.
Uluslararası Ege Zirvesi, 23 - 25 Aralık 2025, (Tam Metin Bildiri)

2. Exploring the Anticancer Efficacy of Newly Synthesized Benzothiazole-Based Molecules in Bladder and Colorectal Carcinoma

ÖZ BEDİR B. E., TERZİ E., ÖZDEMİR SANCI T., Melfi F., KAYA SEZGİNER E., Kaya B., et al.
FEBS-IUBMB-ENABLE 2025 Congress, Glasgow, İngiltere, 10 Eylül 2025, (Özet Bildiri)

3. Evaluating B-Arbutin As An NF-κB Inhibitor In 2D and 3D Colorectal Cancer Cells

TERZİ E., ÖZDEMİR SANCI T., ÖZ BEDİR B. E., GENECİ F., Jafarova S., AYDIN T.
FEBS-IUBMB-ENABLE 2025 Congress, 10 - 12 Eylül 2025, (Özet Bildiri)

4. Evaluating β-Arbutin As An NF-κB Inhibitor In 2D And 3D Colorectal Cancer Cells

TERZİ E., ÖZDEMİR SANCI T., ÖZ BEDİR B. E., GENECİ F., Jafarova S., AYDIN T.
4th FEBS-IUBMB-ENABLE International Molecular Biosciences PhD and Postdoc Conference, Glasgow, İngiltere, 10 Eylül 2025, (Özet Bildiri)

5. Evaluating B-arbutin as an Nf-kB inhibitor in 2D and 3D Colorectal Cancer Cells

TERZİ E., ÖZDEMİR SANCI T., ÖZ BEDİR B. E., GENECİ F., Jafarova S., AYDIN T.
FEBS-IUBMB-ENABLE 2025 Congress, İSKOÇYA, 10 - 12 Eylül 2025, (Özet Bildiri)

6. Determination of herniarin effects on apoptosis and cell cycle in pancreas ductal adenocarcinoma cells

ÖZ BEDİR B. E.
International Conference on Advances in Natural and Applied Sciences (ICANAS 2024), Türkiye, 17 - 20 Nisan 2024, (Tam Metin Bildiri)

7. Cytotoxic and Apoptotic Effects of Acetazolamide in Colorectal Cancer Cells

ÖZDEMİR SANCI T., ÖZ BEDİR B. E., TERZİ E.
3. Uluslararası Tıp Ve Sağlık Bilimlerinde Yenilikçi Yaklaşımlar Kongresi, İstanbul, Türkiye, 7 - 08 Ekim 2023, (Tam Metin Bildiri)

8. APOPTOTIC AND CYTOTOXIC EFFECTS OF HERNIARIN ISOLATED FROM TARRAGON ON SEVERAL CANCER CELL LINES

AYDIN T., ÖZDEMİR SANCI T., TERZİ E., ÖZ BEDİR B. E., ÇAKIR A.
31 INTERNATIONAL SYMPOSIUM ON THE CHEMISTRY OF NATURAL PRODUCTS, 11 INTERNATIONAL CONGRESS ON BIODIVERSITY, Napoli, İtalya, 15 - 19 Ekim 2023, (Özet Bildiri)

9. Cytotoxic And Apoptotic Effects Of Acetazolamıde in Colorectal Cancer Cells

ÖZDEMİR SANCI T., ÖZ BEDİR B. E., TERZİ E.
3. Uluslararası Tıp Ve Sağlık Bilimlerinde Yenilikçi Yaklaşımlar Kongresi, Türkiye, 7 - 08 Ekim 2023, (Tam Metin Bildiri)

10. Targeting Hypoxia in Cancer Treatment

TERZİ E., GÖRGÜN B., ÖZ BEDİR B. E.
Uluslararası Bilimsel Araştırmalar Kongresi, 19 Eylül 2023, (Tam Metin Bildiri)

11. Investigation of Rapamycin on PON1 enzyme levels in colon cancer cell line.

TERZİ E., ÖZ BEDİR B. E., ÖZENSOY GÜLER Ö.
5th International Eurasian Conference on Biological and Chemical Sciences, Türkiye, 23 - 25 Kasım 2022, (Tam Metin Bildiri)

12. Investigation of the Effect of CA-IX Enzyme Inhibiton on the EZH2 Gene and Histone 3 Modifications

KARAKUŞ İ., ÖZ BEDİR B. E., TERZİ E., ÖZENSOY GÜLER Ö.
Uluslarası Biyokimya Kongresi, 26 - 30 Ekim 2022, (Özet Bildiri)

13. The Effect of Acetozolamide on PON1 in HT-29 Cell Line

ÖZ BEDİR B. E., TERZİ E., ÖZENSOY GÜLER Ö.
6th International Conference on Advances in Natural and Applied Sciences, Ağrı, Türkiye, 11 Ekim 2022, (Tam Metin Bildiri)

14. The Effect of Acetozolamide on PON1 in HT-29 Cell Lin

ÖZ BEDİR B. E., TERZİ E., ÖZENSOY GÜLER Ö.
6th International Conference on Advances in Natural and Applied Sciences, Türkiye, 11 Ekim 2022, (Özet Bildiri)

15. Melanom hücre hatlarında borik asit uygulamasının tirozinaz enzim aktivitesi üzerine etkisinin incelenmesi

KILIÇ Ş., UYSAL T. K., ÖZ BEDİR B. E., TERZİ E., ERCAN E., ÖZENSOY GÜLER Ö.
9. Uluslararası Bilimsel Çalışmalar Kongresi, Türkiye, 03 Ağustos 2022, (Özet Bildiri)

16. Borik Asidin Hepatoselüler Karsinom Hücrelerinde Glutatyon Peroksidaz Enzim Aktivitesi Üzerindeki Farklı Etkileri

ÇALIŞKAN B., UYSAL T. K., ŞİMŞEK E., ÖZENSOY GÜLER Ö., TERZİ E., ÖZ BEDİR B. E.
IGSCONG'22, 2. Uluslararası Lisansüstü Çalışmalar Kongresi, Türkiye, 8 - 11 Haziran 2022, (Özet Bildiri)

17. Detection of Circulating Tumor Cells (CTCs) in Various Types of Cancer

TERZİ E., ŞİMŞEK E., ÖZ BEDİR B. E., UYSAL T. K., ERCAN E., ÇARHAN A., et al.
TBS International Biochemistry Congress 2018, Muğla, Türkiye, 26 - 30 Ekim 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

18. The Importance of CTC Heterogeneity

UYSAL T. K., ŞİMŞEK E., ÖZ BEDİR B. E., ERCAN E., TERZİ E., ÖZENSOY GÜLER Ö.
1st International Congress on Cancer and Ion Channels, 21 - 23 Eylül 2017, (Özet Bildiri)

19. The Role of CTC Clusters in Metastasis

ÖZ BEDİR B. E., ŞİMŞEK E., UYSAL T. K., TERZİ E., ERCAN E., ÖZENSOY GÜLER Ö.
1st International Congress on Cancer and Ion Channels, Şanlıurfa, Türkiye, 21 - 23 Eylül 2017, (Özet Bildiri)

20. Detection of Circulating Tumor Cells (CTCs) in Head and Neck Cancer Patients

TERZİ E., ŞİMŞEK E., ÇARHAN A., ERCAN E., UYSAL T. K., ÖZ BEDİR B. E., et al.
1st International Congress on Cancer and Ion Channels, 21 - 23 Eylül 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

21. Detection of Circulating Tumor Cells (CTCs) in Head and Neck Cancer Patients

TERZİ E., ŞİMŞEK E., ÇARHAN A., ERCAN E., UYSAL T. K., ÖZ BEDİR B. E., et al.
1st International Congress on Cancer and Ion Channels, 21 - 23 Eylül 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

22. CA-IX AND CA-XII ISOENZYMES: BIOMARKERS OF CANCER?

ÖZ BEDİR B. E., ŞİMŞEK E., ÖZENSOY GÜLER Ö.
INTERNATIONAL DNA DAY AND GENOME CONGRESS, 24 - 28 Nisan 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

23. EXOSOMES: A NEW GENERATION DRUG DELIVERY VEHICLE IN CANCER

ÖZ BEDİR B. E., ŞİMŞEK E., ÖZENSOY GÜLER Ö.
INTERNATIONAL DNA DAY AND GENOME CONGRESS, 24 - 28 Nisan 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

24. Being a Women in Science

ÖZ B. E., TERZİ E., Arkan T. K., ÇARHAN A., ŞİMŞEK E., ÖZENSOY GÜLER Ö.
1st. Women’s Congress, 14 - 16 Kasım 2016, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

25. Which cells are resistant to the cancer treatment Circulating Tumor Cells CTCs or Cancer Stem Cells CSCs

ERSAN B., ARKAN T. K., ÖZ B. E., ERCAN E., ALTUNDAĞ M. K., ALPARSLAN PINARLI F., et al.
10th ISMRC International Symposium on Minimal Residual Cancer: Liquid Biopsy in Cancer Diagnostics and Treatment, Almanya, 19 - 21 Mart 2016, (Özet Bildiri)

26. A novel strategy for determining circulating tumour cells in lungcancer

Arkan T. K., ÖZ B. E., Ersan B., Ercan E., ŞENDUR M. A. N., Alparslan Pınarlı F., et al.
10th ISMRC International Symposium on Minimal Residual Cancer Liquid Biopsy in Cancer Diagnostic and Treatment, Hamburg, Almanya, 19 - 21 Mart 2016, ss.73

27. A novel strategy for determining circulating tumour cells in lung cancer

ARKAN T. K., ÖZ B. E., ERSAN B., ERCAN E., ŞENDUR M. A. N., ALPARSLAN PINARLI F., et al.
10th ISMRC International Symposium on Minimal Residual Cancer: Liquid Biopsy in Cancer Diagnostics and Treatment, Almanya, 19 - 21 Mart 2016, (Özet Bildiri)

28. Does circulating tumor cell used as a liquid biopsy detector

ÖZ B. E., Arkan T. K., Ersan B., Ercan E., Yalçınkaya T., ŞİMŞEK E., et al.
10th ISMRC International Symposium on Minimal Residual Cancer Liquid Biopsy in Cancer Diagnostic and Treatment, Hamburg, Almanya, 19 - 21 Mart 2016, ss.74

29. A noninvasive method for bladder cancer CTC detection with flow cytometry

ERCAN E., ERSAN B., ARKAN T. K., ÖZ B. E., CANDA A. E., ALPARSLAN PINARLI F., et al.
10th ISMRC International Symposium on Minimal Residual Cancer: Liquid Biopsy in Cancer Diagnostics and Treatment, 19 - 21 Mart 2016

30. Which cells are resistant to the cancer treatment Circulating Tumor Cells CTCs or Cancer Stem Cells CSCs

Ersan B., ARKAN T. K., ÖZ B. E., ERCAN E., ALTUNDAĞ M. K., Alparslan Pınarlı F., et al.
10th ISMRC International Symposium on Minimal Residual Cancer: Liquid Biopsy in Cancer Diagnostics and Treatment, 19 - 21 Mart 2016

31. A novel strategy for determining circulating tumour cells in lung cancer

ARKAN T. K., ÖZ B. E., Bilgesu E., ERCAN E., ŞENDUR M. A. N., Alparslan Pınarlı F., et al.
10th ISMRC International Symposium on Minimal Residual Cancer: Liquid Biopsy in Cancer Diagnostics and Treatment, 19 - 21 Mart 2016

32. Does circulating tumor cell use as a liquid biopsy detector

ÖZ B. E., ARKAN T. K., Ersan B., ERCAN E., Yalçınkaya T., ŞİMŞEK E., et al.
10th ISMRC International Symposium on Minimal Residual Cancer: Liquid Biopsy in Cancer Diagnostics and Treatment, 19 - 21 Mart 2016
Kitaplar 1

1. Clinical trials of chalcone-based drug candidates

TERZİ E., ÖZ BEDİR B. E., ÖZDEMİR SANCI T.
Chalcones From Drug Discovery to Pharmaceutical Applications, Carradori Simone, D'Agostino Ilaria, Moi Davide, Editör, Elsevier, ss.587-606, 2026
Metrikler

Yayın

62

Yayın (Scopus)

21

Atıf (Scopus)

106

H-İndeks (Scopus)

5

Atıf (Scholar)

22

H-İndeks (Scholar)

3

Atıf (TrDizin)

1

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

2

Proje

8

Açık Erişim

1
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER
SDG 16: AMAÇ 16: BARIŞ VE ADALET